Autolus Therapeutics plc develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trials for adult ALL. It also focuses on developing AUTO5, a hematological product candidate, which is in preclinical development.
| Market Cap | 404.676 Million | Shares Outstanding | 173.681 Million | Avg 30-day Volume | 315.56 Thousand |
| P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -1.57 |
| Price to Revenue | 27.158 | Debt to Equity | 0.0 | EBITDA | -158.586 Million |
| Price to Book Value | 0.5783 | Operating Margin | -2642.2327 | Enterprise Value | -210.036 Million |
| Current Ratio | 9.183 | EPS Growth | 0.203 | Quick Ratio | 8.248 |
| 1 Yr BETA | 0.8805 | 52-week High/Low | 3.54 / 1.6 | Profit Margin | -2340.2358 |
| Operating Cash Flow Growth | 4.7115 | Free Cash Flow to Firm (FCFF) TTM | -30.901 Million | Free Cash Flow to Equity (FCFE) TTM | -128.473 Million |
| Altman Z-Score | -1.5486 |
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | ||||||||||||||||
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|---|---|---|---|
| AUTOLUS THERAPEUTICS PLC AUTL | 2023-09-29 22:15:03 UTC | -3.3894 | 8.7094 | 2000000 |
| AUTOLUS THERAPEUTICS PLC AUTL | 2023-09-29 21:45:04 UTC | -3.3894 | 8.7094 | 2000000 |
| AUTOLUS THERAPEUTICS PLC AUTL | 2023-09-29 21:15:03 UTC | -3.3894 | 8.7094 | 2000000 |
| AUTOLUS THERAPEUTICS PLC AUTL | 2023-09-29 20:45:05 UTC | -3.3894 | 8.7094 | 2000000 |
| AUTOLUS THERAPEUTICS PLC AUTL | 2023-09-29 20:15:04 UTC | -3.3603 | 8.6803 | 2000000 |
| AUTOLUS THERAPEUTICS PLC AUTL | 2023-09-29 19:45:04 UTC | -3.3603 | 8.6803 | 2000000 |
| AUTOLUS THERAPEUTICS PLC AUTL | 2023-09-29 19:15:03 UTC | 0.0 | 0.0 | 2000000 |
| AUTOLUS THERAPEUTICS PLC AUTL | 2023-09-29 18:45:03 UTC | 0.0 | 0.0 | 2000000 |
| AUTOLUS THERAPEUTICS PLC AUTL | 2023-09-29 18:15:03 UTC | 0.0 | 0.0 | 2000000 |
| AUTOLUS THERAPEUTICS PLC AUTL | 2023-09-29 17:45:03 UTC | -3.3603 | 8.6803 | 2000000 |
| AUTOLUS THERAPEUTICS PLC AUTL | 2023-09-29 17:15:04 UTC | -3.3603 | 8.6803 | 2000000 |
| AUTOLUS THERAPEUTICS PLC AUTL | 2023-09-29 16:45:04 UTC | -3.3252 | 8.6452 | 2000000 |
| AUTOLUS THERAPEUTICS PLC AUTL | 2023-09-29 16:15:03 UTC | -3.3252 | 8.6452 | 2000000 |
| AUTOLUS THERAPEUTICS PLC AUTL | 2023-09-29 15:45:04 UTC | -3.3252 | 8.6452 | 2000000 |
| AUTOLUS THERAPEUTICS PLC AUTL | 2023-09-29 15:15:04 UTC | -3.3252 | 8.6452 | 2000000 |
| AUTOLUS THERAPEUTICS PLC AUTL | 2023-09-29 14:45:04 UTC | -3.3252 | 8.6452 | 1900000 |
| AUTOLUS THERAPEUTICS PLC AUTL | 2023-09-29 14:15:04 UTC | -3.3252 | 8.6452 | 1900000 |
| AUTOLUS THERAPEUTICS PLC AUTL | 2023-09-29 13:45:03 UTC | -3.1823 | 8.5023 | 1900000 |
| AUTOLUS THERAPEUTICS PLC AUTL | 2023-09-29 13:15:04 UTC | -3.1823 | 8.5023 | 1900000 |
| AUTOLUS THERAPEUTICS PLC AUTL | 2023-09-29 12:45:05 UTC | -3.1823 | 8.5023 | 1900000 |
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|
